Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment

J Cancer Res Clin Oncol. 2017 Jul;143(7):1357-1358. doi: 10.1007/s00432-017-2410-x. Epub 2017 May 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Male
  • Melanoma / drug therapy*
  • Nivolumab
  • Polymyalgia Rheumatica / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Nivolumab